SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma

Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis

Benveniste, H., Drejer, J., Schousboe, A., & Diemer, N. H. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb05396.x · Cited by 2,863

The Dip Test of Unimodality

Hartigan, J. A., & Hartigan, P. M. (1985) · The Annals of Statistics · doi:10.1214/aos/1176346577 · Cited by 2,088

Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy.

Ben-Ari, Y. (1985) · Neuroscience · doi:10.1016/0306-4522(85)90299-4 · Cited by 1,753

Improved Method for Accurate and Efficient Quantification of MRS Data with Use of Prior Knowledge

Vanhamme, L., van den Boogaart, A., & Huffel, S. V. (1997) · Journal of Magnetic Resonance · doi:10.1006/jmre.1997.1244 · Cited by 1,631

Cloning and Expression of a Plasma Membrane Cystine/Glutamate Exchange Transporter Composed of Two Distinct Proteins

Sato, H., Tamba, M., Ishii, T., & Bannai, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11455 · Cited by 1,111

Excitotoxicity and stroke: Identifying novel targets for neuroprotection

Lai, T. W., Zhang, S., & Wang, Y. T. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.11.006 · Cited by 1,106

Java-based graphical user interface for the MRUI quantitation package

Naressi, A., Couturier, C., Devos, J. M., Janssen, M., Mangeat, C., de Beer, R., & Graveron‐Demilly, D. (2001) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/bf02668096 · Cited by 1,003

Glutamate release promotes growth of malignant gliomas

Takano, T., Lin, J. H.-C., Arcuino, G., Gao, Q., Yang, J., & Nedergaard, M. (2001) · Nature Medicine · doi:10.1038/nm0901-1010 · Cited by 610

Glutamate release by primary brain tumors induces epileptic activity

Buckingham, S. C., Campbell, S. L., Haas, B. R., Montana, V., Robel, S., Ogunrinu, T., & Sontheimer, H. (2011) · Nature Medicine · doi:10.1038/nm.2453 · Cited by 578

Exchange of cystine and glutamate across plasma membrane of human fibroblasts.

Bannai, S. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35926-4 · Cited by 549

Ferroptosis: mechanisms, biology and role in disease

Jiang, X., Stockwell, B. R., & Conrad, M. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00324-8 · Cited by 7,973

Broadening horizons: the role of ferroptosis in cancer

Chen, X., Kang, R., Kroemer, G., & Tang, D. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00462-0 · Cited by 3,012

Targeting Ferroptosis as a Vulnerability in Cancer

Lei, G., Zhuang, L., & Gan, B. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00459-0 · Cited by 2,252

Lipid metabolism in cancer: New perspectives and emerging mechanisms

Broadfield, L. A., Pane, A. A., Talebi, A., Swinnen, J. V., & Fendt, S. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.04.013 · Cited by 793

Neuron–glia interactions in the pathophysiology of epilepsy

Patel, D. C., Tewari, B. P., Chaunsali, L., & Sontheimer, H. W. (2019) · Nature reviews. Neuroscience · doi:10.1038/s41583-019-0126-4 · Cited by 478

Breakdown of an Ironclad Defense System: The Critical Role of NRF2 in Mediating Ferroptosis

Anandhan, A., Dodson, M. B., Schmidlin, C. J., Liu, P., & Zhang, D. D. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.03.011 · Cited by 442

ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner

Chen, D., Fan, Z., Rauh, M., Buchfelder, M., Eyupoglu, I. Y., & Savaskan, N. (2017) · Oncogene · doi:10.1038/onc.2017.146 · Cited by 421

Suppression of the SLC7A11/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma

Hu, K., Li, K., Lv, J., Feng, J., Chen, J., Wu, H., Cheng, F., Jiang, W., Wang, J., Pei, H., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124049 · Cited by 409

Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives

Lin, H., Liu, C., Hu, A.-K., Zhang, D., Yang, H., & Mao, Y. Q. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01544-7 · Cited by 462

Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer

Roh, J., Kim, E. H., Jang, H. J., Park, J. Y., & Shin, D. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.07.035 · Cited by 383

Cysteine Metabolism in Neuronal Redox Homeostasis

Paul, B. D., Sbodio, J. I., & Snyder, S. H. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.02.007 · Cited by 356

xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression

Ji, X., Qian, J., Rahman, S. M. J., Siska, P. J., Zou, Y., Harris, B. K., Hoeksema, M. D., Trenary, I. A., Chen, H., Eisenberg, R., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0307-z · Cited by 360

Influence of glutamate and GABA transport on brain excitatory/inhibitory balance

Sears, S. M. S., & Hewett, S. J. (2021) · Experimental Biology and Medicine · doi:10.1177/1535370221989263 · Cited by 371

Targeting SLC7A11 improves efferocytosis by dendritic cells and wound healing in diabetes

Maschalidi, S., Mehrotra, P., Keçeli, B. N., Cleene, H. K. L. D., Lecomte, K., der Cruyssen, R. V., Janssen, P., Pinney, J. J., Loo, G., Elewaut, D. S., et al. (2022) · Nature · doi:10.1038/s41586-022-04754-6 · Cited by 333

Glioblastoma at the crossroads: current understanding and future therapeutic horizons

Singh, S., Dey, D., Barik, D., Mohapatra, I., Kim, S., Sharma, M., Prasad, S., Wang, P., Singh, A. R., & Singh, G. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02299-4 · Cited by 373

Challenges in glioblastoma research: focus on the tumor microenvironment

Bikfalvi, A., da Costa, C. A., Avril, T., Barnier, J., Bauchet, L., Brisson, L., Cartron, P., Castel, H., Chevet, É., Chneiweiss, H., et al. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.09.005 · Cited by 326

Amino Acids and Their Transporters in T Cell Immunity and Cancer Therapy

Wang, W., & Zou, W. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.09.006 · Cited by 313

The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer

Jyotsana, N., Ta, K. T. L., & DelGiorno, K. E. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.858462 · Cited by 290

Tumor Neurobiology and the War of Nerves in Cancer

Faulkner, S., Jobling, P., March, B., Jiang, C. C., & Hondermarck, H. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1398 · Cited by 275

SLC7A11/xCT in cancer: biological functions and therapeutic implications.

Lin, W., Wang, C., Liu, G., Bi, C., Wang, X., Zhou, Q., & Jin, H. (2020) · PubMed · Cited by 264

Molecular basis for redox control by the human cystine/glutamate antiporter system xc−

Parker, J. L., Deme, J. C., Kolokouris, D., Kuteyi, G., Biggin, P. C., Lea, S. M., & Newstead, S. (2021) · Nature Communications · doi:10.1038/s41467-021-27414-1 · Cited by 272

System Xc−: a key regulatory target of ferroptosis in cancer

Liu, M.-R., Zhu, W.-T., & Pei, D. (2021) · Investigational New Drugs · doi:10.1007/s10637-021-01070-0 · Cited by 259

An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment

Verdugo, E., Puerto, I., & Medina, M. Á. (2022) · 癌症：英文版 · doi:10.1002/cac2.12361 · Cited by 250

Human astrocytes in the diseased brain

Dossi, E., Vasile, F., & Rouach, N. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.02.001 · Cited by 250

Cancer metabolism at a glance

Vazquez, A., Kamphorst, J. J., Markert, E. K., Schug, Z. T., Tardito, S., & Gottlieb, E. (2016) · Journal of Cell Science · doi:10.1242/jcs.181016 · Cited by 225

Recent progress of drug nanoformulations targeting to brain

Khan, A. R., Yang, X., Fu, M., & Zhai, G. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.10.004 · Cited by 216

mTORC2 Regulates Amino Acid Metabolism in Cancer by Phosphorylation of the Cystine-Glutamate Antiporter xCT

Gu, Y., de Albuquerque, C. P., Braas, D., Zhang, W., Villa, G. R., Bi, J., Ikegami, S., Masui, K., Gini, B., Yang, H., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.05.030 · Cited by 208

Perineuronal nets decrease membrane capacitance of peritumoral fast spiking interneurons in a model of epilepsy

Tewari, B. P., Chaunsali, L., Campbell, S. L., Patel, D. C., Goode, A. E., & Sontheimer, H. (2018) · Nature Communications · doi:10.1038/s41467-018-07113-0 · Cited by 208

Seizures and gliomas — towards a single therapeutic approach

Huberfeld, G., & Vecht, C. J. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.26 · Cited by 206

Glia as drivers of abnormal neuronal activity

Robel, S., & Sontheimer, H. W. (2015) · Nature Neuroscience · doi:10.1038/nn.4184 · Cited by 198

Remote neuronal activity drives glioma progression through SEMA4F

Huang-Hobbs, E., Cheng, Y.-T., Ko, Y., Luna-Figueroa, E., Lozzi, B., Taylor, K. R., McDonald, M. F., He, P., Chen, H., Yang, Y., et al. (2023) · Nature · doi:10.1038/s41586-023-06267-2 · Cited by 205

Dietary restriction of cysteine and methionine sensitizes gliomas to ferroptosis and induces alterations in energetic metabolism

Upadhyayula, P. S., Higgins, D. M. O., Mela, A., Banu, M. A., Dovas, A., Zandkarimi, F., Patel, P. R., Mahajan, A., Humala, N., Nguyen, T. T. T., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36630-w · Cited by 195

Nrf2 activation in the treatment of neurodegenerative diseases: a focus on its role in mitochondrial bioenergetics and function

Esteras, N., Dinkova‐Kostova, A. T., & Abramov, A. Y. (2016) · Biological Chemistry · doi:10.1515/hsz-2015-0295 · Cited by 163

Epilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapy: Table 1.

Armstrong, T. S., Grant, R., Gilbert, M. R., Lee, J. W., & Norden, A. D. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov269 · Cited by 157

Role and mechanism of ferroptosis in neurological diseases

Ou, M., Jiang, Y., Ji, Y., Zhou, Q., Du, Z., Zhu, H., & Zhou, Z. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101502 · Cited by 150

Increased Expression of System xc− in Glioblastoma Confers an Altered Metabolic State and Temozolomide Resistance

Polewski, M. D., Reveron‐Thornton, R. F., Cherryholmes, G. A., Marinov, G. K., Cassady, K. M., & Aboody, K. S. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0028 · Cited by 142

Sulfasalazine impacts on ferroptotic cell death and alleviates the tumor microenvironment and glioma-induced brain edema

Sehm, T., Fan, Z., Ghoochani, A., Rauh, M., Engelhorn, T., Minakaki, G., Dörfler, A., Klucken, J., Buchfelder, M., Eyüpoglu, I. Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8651 · Cited by 134

Involvement of extrasynaptic glutamate in physiological and pathophysiological changes of neuronal excitability

Pál, B. Z. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2837-5 · Cited by 140

Temozolomide toxicity operates in a xCT/SLC7a11 dependent manner and is fostered by ferroptosis

Sehm, T., Rauh, M., Wiendieck, K., Buchfelder, M., Eyüpoglu, I. Y., & Savaskan, N. E. (2016) · Oncotarget · doi:10.18632/oncotarget.11858 · Cited by 129

Multifaceted Roles of Glutathione and Glutathione-Based Systems in Carcinogenesis and Anticancer Drug Resistance

Hatem, E., Banna, N. E., & Huang, M. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7134 · Cited by 127

Repetitive Diffuse Mild Traumatic Brain Injury Causes an Atypical Astrocyte Response and Spontaneous Recurrent Seizures

Shandra, O. O., Winemiller, A. R., Heithoff, B. P., Muñoz‐Ballester, C., George, K. K., Benko, M. J., Zuidhoek, I. A., Besser, M. N., Curley, D. E., Edwards, G. F., et al. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.1067-18.2018 · Cited by 132

Inhibition of xCT suppresses the efficacy of anti-PD-1/L1 melanoma treatment through exosomal PD-L1-induced macrophage M2 polarization

Liu, N., Zhang, J., Yin, M., Liu, H., Zhang, X., Li, J., Yan, B., Guo, Y., Zhou, J., Tao, J., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.03.013 · Cited by 130

Cystine deprivation triggers CD36-mediated ferroptosis and dysfunction of tumor infiltrating CD8+ T cells

Han, C., Ge, M., Xing, P., Xia, T., Zhang, C., Ma, K., Ma, Y., Li, S., Li, W., Liu, X., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06503-1 · Cited by 116

The EGF Receptor Promotes the Malignant Potential of Glioma by Regulating Amino Acid Transport System xc( — )

Tsuchihashi, K., Okazaki, S., Ohmura, M., Ishikawa, M., Sampetrean, O., Onishi, N., Wakimoto, H., Yoshikawa, M., Seishima, R., Iwasaki, Y., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2121 · Cited by 114

Role of the Microenvironment in Glioma Pathogenesis

Jayaram, M. A., & Phillips, J. J. (2023) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-051122-110348 · Cited by 119

Pathogenesis of peritumoral hyperexcitability in an immunocompetent CRISPR-based glioblastoma model

Hatcher, A., Yu, K., Meyer, J. F., Aiba, I., Deneen, B., & Noebels, J. L. (2020) · Journal of Clinical Investigation · doi:10.1172/jci133316 · Cited by 114

Targeting Glutamine Addiction in Gliomas

Obara‐Michlewska, M., & Szeliga, M. (2020) · Cancers · doi:10.3390/cancers12020310 · Cited by 106

Targeting multidrug resistance-associated protein 1 (MRP1)-expressing cancers: Beyond pharmacological inhibition

Hanssen, K. M., Haber, M., & Fletcher, J. I. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2021.100795 · Cited by 102

Glioma-Induced Alterations in Neuronal Activity and Neurovascular Coupling during Disease Progression

Montgomery, M. K., Kim, S. H., Dovas, A., Zhao, H., Goldberg, A., Xu, W., Yagielski, A. J., Cambareri, M. K., Patel, K., Mela, A., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.03.064 · Cited by 108

Interactions between Tumor Cells, Neurons, and Microglia in the Glioma Microenvironment

Radin, D. P., & Tsirka, S. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228476 · Cited by 101

A synthetic lethal drug combination mimics glucose deprivation–induced cancer cell death in the presence of glucose

Joly, J. H., Delfarah, A., Phung, P. S., Parrish, S., & Graham, N. A. (2020) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)49891-7 · Cited by 97

Ferroptosis in life: To be or not to be

Xu, L., Liu, Y., Chen, X., Zhong, H., & Wang, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114241 · Cited by 100

AMPA receptor antagonist perampanel affects glioblastoma cell growth and glutamate release in vitro

Lange, F., Weßlau, K., Porath, K., Hörnschemeyer, M. F., Bergner, C., Krause, B. J., Mullins, C. S., Linnebacher, M., Köhling, R., & Kirschstein, T. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211644 · Cited by 99

Regulated cell death in cancer: from pathogenesis to treatment

Gong, L., Huang, D., Shi, Y., Liang, Z., & Bu, H. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002239 · Cited by 95

Glutamatergic Mechanisms in Glioblastoma and Tumor-Associated Epilepsy

Lange, F., Hörnschemeyer, M. F., & Kirschstein, T. (2021) · Cells · doi:10.3390/cells10051226 · Cited by 102

Ferroptosis: Cancer Stem Cells Rely on Iron until “to Die for” It

Cosialls, E., Elhage, R., Santos, L. D., Gong, C., Mehrpour, M., & Hamaï, A. (2021) · Cells · doi:10.3390/cells10112981 · Cited by 94

The cystine‐glutamate exchanger (xCT, Slc7a11) is expressed in significant concentrations in a subpopulation of astrocytes in the mouse brain

Ottestad‐Hansen, S., Hu, Q. X., Follin‐Arbelet, V. V., Bentea, E., Sato, H., Massie, A., Zhou, Y., & Danbolt, N. C. (2018) · Glia · doi:10.1002/glia.23294 · Cited by 92

A synthetic lethal drug combination mimics glucose deprivation–induced cancer cell death in the presence of glucose

Joly, J. H., Delfarah, A., Phung, P. S., Parrish, S., & Graham, N. A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011471 · Cited by 88

Glutamate weighted imaging contrast in gliomas with 7 Tesla magnetic resonance imaging

Neal, A. J., Moffat, B. A., Stein, J. M., Nanga, R. P. R., Desmond, P. M., Shinohara, R. T., Hariharan, H., Glarin, R. K., Drummond, K. J., Morokoff, A. P., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101694 · Cited by 90

Glioma epileptiform activity and progression are driven by IGSF3-mediated potassium dysregulation

Curry, R. N., Aiba, I., Meyer, J. F., Lozzi, B., Ko, Y., McDonald, M. F., Rosenbaum, A., Cervantes, A., Huang-Hobbs, E., Cocito, C., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.01.013 · Cited by 88

Pyroptosis, ferroptosis, and autophagy cross-talk in glioblastoma opens up new avenues for glioblastoma treatment

Wan, S., Zhang, G., Liu, R., Abbas, M. N., & Cui, H. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01108-1 · Cited by 92

Ferroptosis in Neurons and Cancer Cells Is Similar But Differentially Regulated by Histone Deacetylase Inhibitors

Zille, M., Kumar, A., Kundu, N., Bourassa, M. W., Wong, V. S. C., Willis, D. E., Karuppagounder, S. S., & Ratan, R. R. (2019) · eNeuro · doi:10.1523/eneuro.0263-18.2019 · Cited by 84

Glioblastoma cells vampirize WNT from neurons and trigger a JNK/MMP signaling loop that enhances glioblastoma progression and neurodegeneration

Portela, M., Venkataramani, V., Fahey-Lozano, N., Seco, E., Losada‐Pérez, M., Winkler, F., & Casas‐Tintó, S. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000545 · Cited by 81

Macrophage xCT deficiency drives immune activation and boosts responses to immune checkpoint blockade in lung cancer

Tang, B., Wang, Y., Xu, W., Zhu, J., Weng, Q., Chen, W., Fang, S., Yang, Y., Qiu, R., Chen, M., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.216021 · Cited by 79

xCT inhibition sensitizes tumors to γ-radiation via glutathione reduction

Cobler, L., Zhang, H., Suri, P., Park, C., & Timmerman, L. (2018) · Oncotarget · doi:10.18632/oncotarget.25794 · Cited by 75

HIF-α activation by the prolyl hydroxylase inhibitor roxadustat suppresses chemoresistant glioblastoma growth by inducing ferroptosis

Su, X., Xie, Y., Zhang, J., Li, M., Zhang, Q., Jin, G., & Liu, F. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05304-8 · Cited by 73

Astrocytes as a target for therapeutic strategies in epilepsy: current insights

Çarçak, N., Onat, F., & Sitnikova, E. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1183775 · Cited by 70

High expression of cystine–glutamate antiporter xCT (SLC7A11) is an independent biomarker for epileptic seizures at diagnosis in glioma

Sørensen, M. F., Heimisdóttir, S. B., Sørensen, M. D., Mellegaard, C. S., Wohlleben, H., Kristensen, B. W., & Beier, C. P. (2018) · Journal of Neuro-Oncology · doi:10.1007/s11060-018-2785-9 · Cited by 68

Ferroptosis-related small-molecule compounds in cancer therapy: Strategies and applications

Yin, L., Liu, P., Jin, Y., Ning, Z., Yang, Y., & Gao, H. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114861 · Cited by 66

Glioblastoma quo vadis : Will migration and invasiveness reemerge as therapeutic targets?

Lefranc, F., Rhun, É. L., Robert Kiss, A., & Weller, M. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.06.017 · Cited by 66

Astrocytes and Epilepsy

Binder, D. K., & Steinhäuser, C. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03236-x · Cited by 70

Regulated Necrotic Cell Death in Alternative Tumor Therapeutic Strategies

Woo, Y., Lee, H.-J., Jung, Y. M., & Jung, Y. (2020) · Cells · doi:10.3390/cells9122709 · Cited by 67

Glioma exosomal microRNA-148a-3p promotes tumor angiogenesis through activating the EGFR/MAPK signaling pathway via inhibiting ERRFI1

Wang, M., Zhao, Y., Yu, Z., Zhang, R.-D., Li, S., Zhang, P., Shan, T.-K., Liu, X., Wang, Z.-M., Zhao, P., et al. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01566-4 · Cited by 63

Hypoxia-Induced Neuronal Activity in Glioma Patients Polarizes Microglia by Potentiating RNA m6A Demethylation

Guo, X., Qiu, W., Li, B., Qi, Y., Wang, S., Zhao, R., Cheng, B., Han, X., Du, H., Pan, Z., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-0430 · Cited by 68

Research progress on SLC7A11 in the regulation of cystine/cysteine metabolism in tumors (Review)

Tang, X., Chen, W., Liu, H., Liu, N., Chen, D., Tian, D., & Wang, J. (2021) · Oncology Letters · doi:10.3892/ol.2021.13165 · Cited by 59

Seizures in glioma patients: An overview of incidence, etiology, and therapies

Samudra, N. P., Zacharias, T., Plitt, A. R., Lega, B. C., & Pan, E. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.07.026 · Cited by 59

Neuronal Activity Promotes Glioma Progression by Inducing Proneural-to-Mesenchymal Transition in Glioma Stem Cells

Guo, X., Qiu, W., Wang, C., Qi, Y., Li, B., Wang, S., Zhao, R., Cheng, B., Han, X., Du, H., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-0609 · Cited by 66

Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies

Mittra, E., Koglin, N., Mosci, C., Kumar, M., Höhne, A., Keu, K. V., Iagaru, A. H., Mueller, A., Berndt, M., Bullich, S., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148628 · Cited by 56

The ubiquitin hydrolase OTUB1 promotes glioma cell stemness via suppressing ferroptosis through stabilizing SLC7A11 protein

Zhao, X., Zhou, M., Yang, Y., & Luo, M. (2021) · Bioengineered · doi:10.1080/21655979.2021.2011633 · Cited by 53

Glial Glutamate Transporter-Mediated Plasticity: System xc-/xCT/SLC7A11 and EAAT1/2 in Brain Diseases

Dahlmanns, M., Dahlmanns, J. K., Savaskan, N. E., Steiner, H. H., & Yakubov, E. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2803057 · Cited by 53

Astrocytes and Epilepsy

Binder, D. K., & Steinhäuser, C. (2016) · Elsevier eBooks · doi:10.1016/c2014-0-03100-0 · Cited by 53

A map of the altered glioma metabolism

Deshmukh, R. S., Allega, M. F., & Tardito, S. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.07.011 · Cited by 53

SLC7A11 promotes the progression of gastric cancer and regulates ferroptosis through PI3K/AKT pathway

Jiang, Y., Cui, J., Cui, M., & Jing, R. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154646 · Cited by 50

SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma

Ma, Z., Zhang, H., Lian, M., Yue, C., Dong, G., Jin, Y., Li, R., Wan, H., Wang, R., Wang, Y., et al. (2017) · Oncology Reports · doi:10.3892/or.2017.5976 · Cited by 48

Potassium and glutamate transport is impaired in scar-forming tumor-associated astrocytes

Campbell, S. C., Muñoz‐Ballester, C., Chaunsali, L., Mills, W. A., Yang, J. H., Sontheimer, H. W., & Robel, S. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104628 · Cited by 50

LncRNA T-UCR Uc.339/miR-339/SLC7A11 Axis Regulates the Metastasis of Ferroptosis-Induced Lung Adenocarcinoma

Zhang, N., Huang, J., Xu, M., & Wang, Y. (2022) · Journal of Cancer · doi:10.7150/jca.65017 · Cited by 47

Does the choice of antiepileptic drug affect survival in glioblastoma patients?

Knudsen-Baas, K. M., Engeland, A., Gilhus, N. E., Storstein, A. M., & Owe, J. F. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2191-0 · Cited by 47

Upregulation of the solute carrier family 7 genes is indicative of poor prognosis in papillary thyroid carcinoma

Shen, L., Qian, C., Cao, H., Wang, Z., Luo, T., & Liang, C. (2018) · World Journal of Surgical Oncology · doi:10.1186/s12957-018-1535-y · Cited by 47

Multi‐omics technologies and molecular biomarkers in brain tumor‐related epilepsy

Du, Y., Li, R., Fu, D., Zhang, B., Cui, A., Shao, Y., Lai, Z., Chen, R., Chen, B., Wang, Z., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14717 · Cited by 45

Membrane Transporters for Amino Acids as Players of Cancer Metabolic Rewiring

Scalise, M., Console, L., Rovella, F., Galluccio, M., Pochini, L., & Indiveri, C. (2020) · Cells · doi:10.3390/cells9092028 · Cited by 45

Dysregulation of Ambient Glutamate and Glutamate Receptors in Epilepsy: An Astrocytic Perspective

Alcoreza, O. B., Patel, D. C., Tewari, B. P., & Sontheimer, H. W. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.652159 · Cited by 44

Comparative analysis of antibodies to xCT (Slc7a11): Forewarned is forearmed

Liefferinge, J. V., Bentea, E., Demuyser, T., Albertini, G., Follin-Arbelet, V. V., Holmseth, S., Merckx, E., Sato, H., Aerts, J. L., Smolders, I. J., et al. (2015) · The Journal of Comparative Neurology · doi:10.1002/cne.23889 · Cited by 44

Inhibition of SLC7A11 by Sulfasalazine Enhances Osteogenic Differentiation of Mesenchymal Stem Cells by Modulating BMP2/4 Expression and Suppresses Bone Loss in Ovariectomized Mice

Jin, C., Zhang, P., Zhang, M., Zhang, X., Lv, L., Liu, H., Liu, Y., & Zhou, Y. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3009 · Cited by 44

Mesenchymal stem cell-derived extracellular vesicles prevent glioma by blocking M2 polarization of macrophages through a miR-744-5p/TGFB1-dependent mechanism

Liu, L., Cheng, M., Zhang, T., Chen, Y., Wu, Y., & Wang, Q. (2022) · Cell Biology and Toxicology · doi:10.1007/s10565-021-09652-7 · Cited by 44

mTOR-Mediated Antioxidant Activation in Solid Tumor Radioresistance

Woo, Y., Lee, H.-J., Jung, Y. M., & Jung, Y. (2019) · Journal of Oncology · doi:10.1155/2019/5956867 · Cited by 42

Ferroptosis participates in dibutyl phthalate-aggravated allergic asthma in ovalbumin-sensitized mice

Li, Y., Yan, B., Wu, Y., Peng, Q., Wei, Y., Chen, Y., Zhang, Y., Ma, N., Xu, Y., & Ma, P. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.114848 · Cited by 42

Emerging role of ferroptosis in glioblastoma: Therapeutic opportunities and challenges

Zhuo, S., He, G., Chen, T., Li, X., Liang, Y., Wu, W., Weng, L., Feng, J., Gao, Z., & Yang, K. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.974156 · Cited by 45

Potassium ion channel modulation at cancer-neural interface enhances neuronal excitability in epileptogenic glioblastoma multiforme

Zhang, Y., Duan, W., Chen, L., Chen, J., Xu, W., Fan, Q., Li, S., Liu, Y., Wang, S., He, Q., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.10.016 · Cited by 44

Review: Molecular characteristics of long‐term epilepsy‐associated tumours (LEATs) and mechanisms for tumour‐related epilepsy (TRE)

Stone, T. J., Rowell, R., Jayasekera, B. A. P., Cunningham, M. O., & Jacques, T. S. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12459 · Cited by 40

Seizures as presenting symptom in patients with glioblastoma

Dührsen, L., Sauvigny, T., Ricklefs, F. L., Mende, K. C., Schaper, M., Matschke, J., Goebell, E., Westphal, M., & Martens, T. (2018) · Epilepsia · doi:10.1111/epi.14615 · Cited by 41

Highlights from the Literature

Bhat, K., Pope, W., Huse, J. T., Hegi, M. E., & Aldape, K. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov252

Excitotoxic SLC7A11 Expression Is a Marker of Poor Glioblastoma Survival and a Potential Therapeutic Target

Zhang, R. R., Pointer, K. B., & Kuo, J. S. (2015) · Neurosurgery · doi:10.1227/01.neu.0000473809.76102.ee · Cited by 11

Glioma, glutamate (SLC7A11) and seizures—a commentary

Santosh, V., & Palavalasa, S. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.02.18 · Cited by 9

High expression of cystine–glutamate antiporter xCT (SLC7A11) is an independent biomarker for epileptic seizures at diagnosis in glioma

Sørensen, M. F., Heimisdóttir, S. B., Sørensen, M. D., Mellegaard, C. S., Wohlleben, H., Kristensen, B. W., & Beier, C. P. (2018) · Journal of Neuro-Oncology · doi:10.1007/s11060-018-2785-9 · Cited by 68

The role of glutamate transport and SLC7A11 expression in tumor-associate seizures and survival in patients with malignant gliomas

Keen, J. R., Swanger, S. A., Traynelis, S. F., & Olson, J. J. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.10.23 · Cited by 1